Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000252864 | SCV000320494 | likely benign | Cardiovascular phenotype | 2016-10-27 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: Intact protein function observed in appropriate functional assay(s),In silico models in agreement (benign) |
Invitae | RCV000707524 | SCV000836625 | uncertain significance | Long QT syndrome | 2018-03-26 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with leucine at codon 967 of the KCNH2 protein (p.Pro967Leu). The proline residue is weakly conserved and there is a moderate physicochemical difference between proline and leucine. This variant is present in population databases (rs199473016, ExAC 0.2%), and has an allele count higher than expected for a pathogenic variant (PMID: 28166811). This variant has been reported in an individual affected with sudden infant death syndrome as well as in a healthy control (PMID: 14975928). ClinVar contains an entry for this variant (Variation ID: 67451). Experimental studies have shown that this missense change is electrophysiologically indistinguishable from the wild type channel (PMID:14975928). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Cardiovascular Biomedical Research Unit, |
RCV000058178 | SCV000089698 | not provided | not provided | no assertion provided | literature only | This variant has been reported in the following publications (PMID:14661677;PMID:19841300). |